Fiche centre
MD Anderson Cancer Center
Houston — United States
Essais liés9clinical trials
VilleHoustonlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07764744
Essais cliniques associés
9| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| ACT-Together (Acting on Cancer Testing-Together) | Cancer | Non applicable | NCT06549153 | ACT-Together (Acting on Cancer Testing-Together) | ACTIVE_NOT_RECRUITING |
| Tacabrutideg | Cancer | Phase 1/2 | NCT05006716 | CaDAnCe-101 — A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies | RECRUITING |
| Psilocybin | Cancer | Phase 2 | NCT06200155 | Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy | RECRUITING |
| JNJ-101556143 Formulation 1 | Cancer | Phase 1/2 | NCT06800313 | Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer | RECRUITING |
| Evaluation of Hereditary Cancer Educational Videos | Cancer | À vérifier | NCT06157801 | Evaluation of Hereditary Cancer Educational Videos | ACTIVE_NOT_RECRUITING |
| An Evaluation of the Implementation of the Care and Monitoring at Home Program- A New Paradigm for Acute Care Management of Cancer Patients | Cancer | À vérifier | NCT05904899 | An Evaluation of the Implementation of the Care and Monitoring at Home Program- A New Paradigm for Acute Care Management of Cancer Patients | SUSPENDED |
| Galleri Multi-Cancer Early Detection (MCED) Blood Test | Cancer | Non applicable | NCT07764744 | OC-LEAD — Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic Variants | NOT_YET_RECRUITING |
| Risk Communication Within Mexican-American Families | Cancer | À vérifier | NCT00469339 | Risk Communication Within Mexican-American Families | COMPLETED |
| Robotic-Assisted Surgery | Myasthénie | Non applicable | NCT05150210 | SP Thoracic IDE Study | ACTIVE_NOT_RECRUITING |